Additionally, Koffeman et al. developed an immunotherapy for rheumatoid arthritis using a peptide fragment of DNAJP1, a DNAJ family member, highlighting the utility of HSP40/DNAJ family proteins as potential therapies for autoimmune diseases [311]. This evidence concerns the gene DNAJB1 and rheumatoid arthritis.